Ki-67 Index and Somatostatin Receptor Expression As Prognostic Markers in Patients With Pancreatic Neuroendocrine Tumours: A Review. AGDD 2025, 8 (1), 5-9. https://doi.org/10.5281/zenodo.22202865.